International Stem Cell CORP (ISCO) community

ISCOOTCPharmaceutical PreparationsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 1/30

$0.28+0.00 (+0.89%)

Close on Oct 19, 2026Market cap $2.27MP/E –Yield –

Community

Notes and questions about International Stem Cell from other investors

No posts about ISCO yet

Discussion is coming to every stock. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.

Where these numbers come from

Parsed from the XBRL in International Stem Cell's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-150 reverse split on Jul 29, 2015
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is ISCO.

Compare: ISCO vs APLM · ISCO vs CELU · ISCO vs PRAX · ISCO vs CAPR · ISCO vs LCTX

Revenue growth3.4% · median -29.0%

Operating margin-4.7% · median -272.3%

Net margin-6.1% · median -114.7%

Company	Revenue	Growth
CELU	$18.67M	-58.1%
LCTX	$10.84M	+0.2%
ISCO	$9.51M	+3.4%
APLM	–	–
PRAX	–	–
CAPR	–	–

Company

Exchange: OTC
Industry: Pharmaceutical Preparations
Fiscal year ends: December 31
Employees: 33
Auditor: BDO USA, P.C.
SEC CIK: 1355790

Advertisement
300 × 250

See a number that looks wrong?